Please use this identifier to cite or link to this item: http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/2409
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, K.-
dc.contributor.authorSinha, M.-
dc.contributor.authorPal, D.-
dc.contributor.authorTabasum, S.-
dc.contributor.authorGnyawali, S. C.-
dc.contributor.authorKhona, D.-
dc.contributor.authorSarkar, S.-
dc.contributor.authorMohanty, S. K.-
dc.contributor.authorGonzalez, F. S.-
dc.contributor.authorKhanna, S.-
dc.contributor.authorRoy, S.-
dc.contributor.authorSen, C. K.-
dc.date.accessioned2021-08-18T22:36:59Z-
dc.date.available2021-08-18T22:36:59Z-
dc.date.issued2021-08-19-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2409-
dc.description.abstractEpithelial to mesenchymal transition (EMT) and wound vascularization are two critical interrelated processes that enable cutaneous wound healing. Zinc finger E-box binding homeobox 1 (ZEB1), primarily studied in the context of tumor biology, is a potent EMT activator. ZEB1 is also known to contribute to endothelial cell survival as well as stimulate tumor angiogenesis. The role of ZEB1 in cutaneous wounds was assessed using Zeb11/2 mice, as Zeb12/2 mice are not viable. Quantitative stable isotope labeling by amino acids in cell culture (SILAC) proteomics was used to elucidate the effect of elevated ZEB1, as noted during hyperglycemia. Under different glycemic conditions, ZEB1 binding to E-cadherin promoter was investigated using chromatin immunoprecipitation. Cutaneous wounding resulted in loss of epithelial marker E-cadherin with concomitant gain of ZEB1. The dominant proteins downregulated after ZEB1 overexpression functionally represented adherens junction pathway. Zeb11/2 mice exhibited compromised wound closure complicated by defective EMT and poor wound angiogenesis. Under hyperglycemic conditions, ZEB1 lost its ability to bind E-cadherin promoter. Keratinocyte E-cadherin, thus upregulated, resisted EMT required for wound healing. Diabetic wound healing was improved in ZEB1/2 as well as in db/db mice subjected to ZEB1 knockdown. This work recognizes ZEB1 as a key regulator of cutaneous wound healing that is of particular relevance to diabetic wound complicationen_US
dc.language.isoen_USen_US
dc.titleCutaneous epithelial to mesenchymal transition activator ZEB1 regulates wound angiogenesis and closure in a glycemic status–dependent manneren_US
dc.typeArticleen_US
Appears in Collections:Year-2019

Files in This Item:
File Description SizeFormat 
Full Text.pdf1.24 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.